269 episodes

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerVoice Internal Medicine Video PeerVoice

    • Science

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

    • video
    Non-Oncotic Methods for Managing the Milieu of Decompensated Liver Cirrhosis

    Non-Oncotic Methods for Managing the Milieu of Decompensated Liver Cirrhosis

    Visit https://www.peervoice.com/YAP860 to view the entire programme with slides. After completing “Non-Oncotic Methods for Managing the Milieu of Decompensated Liver Cirrhosis”, participants will be able to: Describe the non-oncotic properties of human albumin and how they relate to the pathology of decompensated cirrhosis; Define the importance of the dosing and administration regimen for human albumin in patients with decompensated cirrhosis and the evidence that supports this approach; Apply practical strategies to identify those patients who will benefit most from a human albumin plus standard medical therapy (SMT) regimen.

    • 18 min
    • video
    Beyond Traditional MHT to Address Menopause Symptoms: A Shared Decision-Making Process

    Beyond Traditional MHT to Address Menopause Symptoms: A Shared Decision-Making Process

    Visit https://www.peervoice.com/HVG860 to view the entire programme with slides. After completing “Beyond Traditional MHT to Address Menopause Symptoms: A Shared Decision-Making Process”, participants will be able to: Outline key data and differences between traditional menopausal hormone therapy (MHT) and tissue selective estrogen complex (TSEC) to guide treatment selection for menopause symptoms.

    • 20 min
    • video
    Clinical Conundrums in Type 2 Diabetes: Managing Challenging Cases in Primary Care

    Clinical Conundrums in Type 2 Diabetes: Managing Challenging Cases in Primary Care

    Visit https://www.peervoice.com/QNV860 to view the entire programme with slides. After completing “Clinical Conundrums in Type 2 Diabetes: Managing Challenging Cases in Primary Care”, participants will be able to: Recognise the common barriers to add-on therapy for patients with type 2 diabetes (T2DM) in the primary care setting and consequences of undertreatment; Evaluate current clinical trial data for GLP-1 receptor agonists (RAs) in the management of patients with T2DM; Design strategies to address key barriers to optimal, evidence-based treatment algorithms for patients with T2DM.

    • 27 min
    • video
    Optimising Use of Traditional Oral Glucose-Lowering Therapies in Type 2 Diabetes: Important for Patients and Society!

    Optimising Use of Traditional Oral Glucose-Lowering Therapies in Type 2 Diabetes: Important for Patients and Society!

    Visit https://www.peervoice.com/DMU860 to view the entire programme with slides. After completing “Optimising Use of Traditional Oral Glucose-Lowering Therapies in Type 2 Diabetes: Important for Patients and Society!”, participants will be able to: Discuss the place in therapy for traditional oral glucose-lowering medications and the rationale for their continued use; Appraise the recent data on cardiovascular safety and hypoglycaemia associated with sulphonylureas (SUs); Identify factors that would indicate suitability of a patient with type 2 diabetes for an SU and how treatment could be individualised to optimise outcomes.

    • 17 min
    • video
    Clinical Developments in Managing Autoinflammatory Diseases

    Clinical Developments in Managing Autoinflammatory Diseases

    Visit https://www.peervoice.com/NHZ860 to view the entire programme with slides. After completing “Clinical Developments in Managing Autoinflammatory Diseases”, participants will be able to: Describe the impact of the latest data and clinical evidence on therapeutic strategies for patients with autoinflammatory diseases; Identify how the clinical features and disease activity associated with autoinflammatory diseases impact patient outcomes, QOL, and treatment considerations; Propose clinical, immunologic, and practical considerations for managing and vaccinating patients with autoinflammatory diseases during the COVID-19 pandemic.

    • 30 min
    • video
    Improving Outcomes in Non-Metastatic CRPC: Case by Case

    Improving Outcomes in Non-Metastatic CRPC: Case by Case

    Visit https://www.peervoice.com/ZYF860 to view the entire programme with slides. After completing “Improving Outcomes in Non-Metastatic CRPC: Case by Case”, participants will be able to: Evaluate clinical data in terms of implications for patient care; Recognise patient-driven goals of therapy for non-metastatic castration-resistant prostate cancer (nmCRPC) in addition to clinical goals of therapy; Formulate individualised treatment plans for patients with nmCRPC.

    • 19 min

Top Podcasts In Science

More by PeerVoice